Fredrick C Hagemeister: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia

Professor Fredrick Hagemeister

Journal:

Year:

2010

Language:

english

File:

PDF, 158 KB

english, 2010

2

De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era

Hu, Bei, Nastoupil, Loretta J., Loghavi, Sanam, Westin, Jason R., Thakral, Beenu, Fayad, Luis E., Hagemeister, Fredrick, Neelapu, Sattva, Samaniego, Felipe, Lee, Hun J., Wang, Michael L., Fanale, Mich

Journal:

Leukemia and Lymphoma

Year:

2019

Language:

english

File:

PDF, 1.41 MB

english, 2019

3

A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study

Yu, Li, Shi, Menghan, Cai, Qingqing, Strati, Paolo, Hagemeister, Fredrick, Zhai, Qiongli, Li, Ling, Fang, Xiaosheng, Li, Jianyong, Sun, Ruifang, Zhang, Shanxiang, Yang, Hanjin, Wang, Zhaoming, Qian, W

Journal:

Year:

2020

File:

PDF, 1.27 MB

2020

4

Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy

Roger W. Rodgers, Lillian M. Fuller, Fredrick B. Hagemeister, Dennis A. Johnston, Jane A. Sullivan, Luceil B. North, James J. Butler, Williams S. Velasquez, Fred G. Conrad, C. C. Shullenberger

Journal:

Year:

1981

Language:

english

File:

PDF, 748 KB

english, 1981

5

Treatment of patients with stages I and II nonmediastinal Hodgkin's disease

Fredrick B. Hagemeister, Lillian M. Fuller, Jane A. Sullivan, Dennis Johnston, Luceil North, James J. Butler, W. S. Velasquez, C. C. Shullenberger

Journal:

Year:

1982

Language:

english

File:

PDF, 570 KB

english, 1982

6

Diagnosis and management of Hodgkin's disease in the adult

Lillian M. Fuller, Fredrick B. Hagemeister

Journal:

Year:

1983

Language:

english

File:

PDF, 867 KB

english, 1983

7

Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas

William Velasquez, Lillian M. Fuller, Kyoung K. Oh, Fredrick B. Hagemeister, Jane A. Sullivan, John T. Manning, C. C. Shullenberger

Journal:

Year:

1984

Language:

english

File:

PDF, 483 KB

english, 1984

8

Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin

G. Narayana Pillai, Fredrick B. Hagemeister, William S. Velasquez, Jane A. Sullivan, Dennis A. Johnston, James J. Butler, C. C. Shullenberger

Journal:

Year:

1985

Language:

english

File:

PDF, 700 KB

english, 1985

9

Incidence of lymphoma in the US classified by the working formulation

Guy R. Newell, Fernando G. Cabanillas, Fredrick J. Hagemeister, James J. Butler

Journal:

Year:

1987

Language:

english

File:

PDF, 477 KB

english, 1987

10

Role of the gallium scan in Hodgkin's disease

Fredrick B. Hagemeister, Susan M. Fesus, Lamk M. Lamki, Thomas P. Haynie

Journal:

Year:

1990

Language:

english

File:

PDF, 641 KB

english, 1990

11

Treatment of lower torso stages I and Ii Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone

Stanley S. Givens, Lillian M. Fuller, Fredrick B. Hagemeister, Edmund A. Gehan

Journal:

Year:

1990

Language:

english

File:

PDF, 614 KB

english, 1990

12

Surgical debulking is associated with improved survival in stage I–II diffuse large cell lymphoma

Jorge E. Romaguera, William S. Velasquez, Karen B. Silvermintz, Lillian B. Fuller, Fredrick B. Hagemeister, Peter McLaughlin, Fernando Cabanillas

Journal:

Year:

1990

Language:

english

File:

PDF, 641 KB

english, 1990

13

Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis

William S. Velasquez, Peter McLaughlin, Lillian M. Fuller, Pamela K. Allen, Susan L. Tucker, Forrest Swan Jr., Maria A. Rodriguez, Fredrick B. Hagemeister, Fernando F. Cabanillas

Journal:

Year:

1994

Language:

english

File:

PDF, 808 KB

english, 1994

14

Frequency of minisatellite repeat number changes at the MS205 locus in human sperm before and after cancer chemotherapy

Ningjia Zheng, Darren G. Monckton, Gene Wilson, Fredrick Hagemeister, Ranajit Chakraborty, Thomas H. Connor, Michael J. Siciliano, Marvin L. Meistrich

Journal:

Environmental and Molecular Mutagenesis

Year:

2000

Language:

english

File:

PDF, 114 KB

english, 2000

15

Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature

Andres O. Soriano, Michael A. Thompson, Joan H. Admirand, Luis E. Fayad, Alma M. Rodriguez, Jorge E. Romaguera, Fredrick B. Hagemeister, Barbara Pro

Journal:

American Journal of Hematology

Year:

2007

Language:

english

File:

PDF, 160 KB

english, 2007

16

Hodgkin disease in a patient with common variable immunodeficiency

Susan M. Fesus, Dr. Fredrick B. Hagemeister, John Manning

Journal:

American Journal of Hematology

Year:

1989

Language:

english

File:

PDF, 734 KB

english, 1989

17

ChemInform Abstract: Cavity—Ringdown Methods for Studying Intramolecular and Intermolecular Dynamics

Fredrick C. Hagemeister, Caleb A. Arrington, Brent J. Giles, Bobby Quimpo, Limin Zhang, Timothy S. Zwier

Journal:

Year:

1999

File:

PDF, 25 KB

1999

18

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease

Richard B. Wilder, Pamela J. Schlembach, Dan Jones, Gregory M. Chronowski, Chul S. Ha, Anas Younes, Fredrick B. Hagemeister, Ibrahim Barista, Fernando Cabanillas, James D. Cox

Journal:

Year:

2002

Language:

english

File:

PDF, 142 KB

english, 2002

19

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, Ibrahim Barista, Mark A. Hess, Fernando Cabanillas, James D. Cox

Journal:

Year:

2002

Language:

english

File:

PDF, 78 KB

english, 2002

20

Thalidomide for patients with recurrent lymphoma

Barbara Pro, Anas Younes, Maher Albitar, Nam H. Dang, Felipe Samaniego, Jorge Romaguera, Peter McLaughlin, Fredrick B. Hagemeister, Maria A. Rodriguez, Marilyn Clemons, Fernando Cabanillas

Journal:

Year:

2004

Language:

english

File:

PDF, 71 KB

english, 2004

21

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Apostolia-Maria Tsimberidou, Anas Younes, Jorge Romaguera, Fredrick B. Hagemeister, Maria A. Rodriguez, Lei Feng, Ana Ayala, Terry L. Smith, Fernando Cabanillas, Peter McLaughlin

Journal:

Year:

2005

Language:

english

File:

PDF, 180 KB

english, 2005

22

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

Yasuhiro Oki, Peter McLaughlin, Barbara Pro, Fredrick B. Hagemeister, Archie Bleyer, Evelyn Loyer, Anas Younes

Journal:

Year:

2005

Language:

english

File:

PDF, 143 KB

english, 2005

23

Hodgkin transformation of chronic lymphocytic leukemia : The M. D. Anderson Cancer Center experience

Apostolia-Maria Tsimberidou, Susan O'Brien, Hagop M. Kantarjian, Charles Koller, Fredrick B. Hagemeister, Luis Fayad, Susan Lerner, Carlos E. Bueso-Ramos, Michael J. Keating

Journal:

Year:

2006

Language:

english

File:

PDF, 220 KB

english, 2006

24

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

Elias Jabbour, Chitra Hosing, Gregory Ayers, Rodolfo Nunez, Paolo Anderlini, Barbara Pro, Issa Khouri, Anas Younes, Fredrick Hagemeister, Larry Kwak, Luis Fayad

Journal:

Year:

2007

Language:

english

File:

PDF, 201 KB

english, 2007

25

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

Yasuhiro Oki, Barbara Pro, Luis E. Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva Neelapu, Peter McLaughlin, Andre Goy, Anas Younes

Journal:

Year:

2008

Language:

english

File:

PDF, 80 KB

english, 2008

26

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

Michael Wang, Luis Fayad, Fernando Cabanillas, Fredrick Hagemeister, Peter McLaughlin, Maria A Rodriguez, Larry W. Kwak, Yuhong Zhou, Hagop Kantarjian, Jorge Romaguera

Journal:

Year:

2008

Language:

english

File:

PDF, 119 KB

english, 2008

27

Prognostic factors in decision-making in the clinical management of Hodgkin's disease

Fredrick B. Hagemeister

Journal:

Hematological Oncology

Year:

1988

Language:

english

File:

PDF, 1.72 MB

english, 1988

28

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage ia through iib hodgkin's disease: Preliminary results

Lillian M. Fuller, Fredrick B. Hagemeister, Luceil B. North, Peter McLaughlin, William S. Velasquez, Fernando Cabanillas

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1988

Language:

english

File:

PDF, 1.18 MB

english, 1988

29

Significance of tumor size and radiation dose to local control in Stage I–III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

Lillian M. Fuller, Matthew J. Krasin, William S. Velasquez, Pamela K. Allen, Peter McLaughlin, M.Alma Rodriguez, Fredrick B. Hagemeister, Forrest Swan Jr., Fernando Cabanillas, Judy L. Palmer, James D

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1995

Language:

english

File:

PDF, 995 KB

english, 1995

30

2042 Long term outcome of treatment for ann arbor stage I Hodgkin's disease: Prognostic factors for survival and freedom from progression

Maria T. Vlachaki, Fredrick B. Hagemeister, Lillian M. Fuller, Pelayo C. Besa, Mark A. Hess, Fernando Cabanillas, James D. Cox

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1995

Language:

english

File:

PDF, 101 KB

english, 1995

31

Resonant ion-dip infrared spectroscopy of benzene–(water)n–(methanol)m clusters with n+m=4, 5

Fredrick C Hagemeister, Christopher J Gruenloh, Timothy S Zwier

Journal:

Chemical Physics

Year:

1998

Language:

english

File:

PDF, 324 KB

english, 1998

32

Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy

Gregory M Chronowski, Richard B Wilder, Susan L Tucker, Chul S Ha, Anas Younes, Luis Fayad, Maria A Rodriguez, Fredrick B Hagemeister, Ibrahim Barista, Fernando Cabanillas, James D Cox

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2003

Language:

english

File:

PDF, 97 KB

english, 2003

33

Hodgkin's disease: Correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II

Lillian M. Fuller, Nadeem Q. Mirza, J.Lynn Palmer, Barry R. Davis, Chul S. Ha, M.Alma Rodriguez, Fredrick B. Hagemeister, Fernando Cabanillas, Peter McLaughlin, James J. Butler, Luceil B. North, Richa

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1998

Language:

english

File:

PDF, 1.15 MB

english, 1998

34

2163 Subdiaphragmatic stage I & II Hodgkin's disease-long-term follow-up and prognostic factors

Zhongxing Liao, Chul S. Ha, Lillian M. Fuller, Fredrick B. Hagemeister, Fernando Cabanillas, Susan L. Tucker, Mark A. Hess, James D. Cox

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1997

Language:

english

File:

PDF, 128 KB

english, 1997

35

21 Long term outcome of treatment for Ann Arbor stage I Hodgkin's disease: Patterns of failure, late toxicity and second malignancies

Maria T. Vlachaki, Fredrick B. Hagemeister, Lillian M. Fuller, Maria A. Rodriguez, Pelayo C. Besa, Mark A. Hess, Barry Brown, Fernando Cabanillas, James D. Cox

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

36

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

Fredrick B. Hagemeister

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2002

Language:

english

File:

PDF, 98 KB

english, 2002

37

Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?

Deborah A. Thomas, Susan O’Brien, Stefan Faderl, John T. Manning, Jorge Romaguera, Luis Fayad, Fredrick Hagemeister, Jeffrey Medeiros, Jorge Cortes, Hagop Kantarjian

Journal:

Current Hematologic Malignancy Reports

Year:

2011

Language:

english

File:

PDF, 167 KB

english, 2011

38

Maintenance and Consolidation Strategies in Non-Hodgkin’s Lymphoma: A Review of the Data

Fredrick B. Hagemeister

Journal:

Current Oncology Reports

Year:

2010

Language:

english

File:

PDF, 150 KB

english, 2010

39

Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease

Shiao Y. Woo, Lillian M. Fuller, Jackson H. Cundiff, Melissa L. Bondy, Fredrick B. Hagemeister, Peter McLaughlin, William S. Velasquez, Forrest Swan Jr., M. Alma Rodriguez, Fernando Cabanillas, Pamela

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1992

Language:

english

File:

PDF, 895 KB

english, 1992

40

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

Zhongxing Liao, Chul S Ha, Lillian M Fuller, Fredrick B Hagemeister, Fernando Cabanillas, Susan L Tucker, Mark A Hess, James D Cox

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1998

Language:

english

File:

PDF, 86 KB

english, 1998

41

Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma

Nam H. Dang, Barbara Pro, Fredrick B. Hagemeister, Felipe Samaniego, Dan Jones, Barry I. Samuels, Maria A. Rodriguez, Andre Goy, Jorge E. Romaguera, Peter McLaughlin, Ann T. Tong, Francesco Turturro,

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 507 KB

english, 2007

42

Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma

Nam H. Dang, Luis Fayad, Peter McLaughlin, Jorge E. Romaguara, Fredrick Hagemeister, Andre Goy, Sattva Neelapu, Felipe Samaniego, Pamela L. Walker, Michael Wang, Maria A. Rodriguez, Ann T. Tong, Barba

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 447 KB

english, 2007

43

Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

Barbara Pro, Brian Leber, Mitchell Smith, Luis Fayad, Jorge Romaguera, Fredrick Hagemeister, Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James Zwiebel, Adriana Lopez, Larry Kwak, Anas Younes

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 168 KB

english, 2008

44

Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

Jorge E. Romaguera, Luis E. Fayad, Lei Feng, Kimberly Hartig, Pamela Weaver, Maria Alma Rodriguez, Fredrick B. Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Andre Goy, Fer

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 194 KB

english, 2010

45

Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm

Robbins, Wendie A., Meistrich, Marvin L., Moore, Dan, Hagemeister, Fredrick B., Weier, Heinz-Ulrich, Cassel, Michael J., Wilson, Gene, Eskenazi, Brenda, Wyrobek, Andrew J.

Journal:

Nature Genetics

Year:

1997

File:

PDF, 558 KB

1997

46

Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination

Jorge E. Romaguera, M. Alma Rodriguez, Fredrick B. Hagemeister, Peter McLaughlin, Jose Rodriguez, Alejandro Preti, Anas Younes, Andreas H. Sarris, Fernando Cabanillas

Journal:

Investigational New Drugs

Year:

1999

Language:

english

File:

PDF, 52 KB

english, 1999

47

Low-grade lymphomas: new entities and treatment concepts

Fredrick B. Hagemeister

Journal:

Medical Oncology

Year:

1995

Language:

english

File:

PDF, 1.37 MB

english, 1995

48

Density Functional Theory Calculations of the Structures, Binding Energies, and Infrared Spectra of Methanol Clusters

Hagemeister, Fredrick C., Gruenloh, Christopher J., Zwier, Timothy S.

Journal:

Journal of Physical Chemistry A

Year:

1998

Language:

english

File:

PDF, 268 KB

english, 1998

49

Incidence and Risk Factors of Venous Thromboembolic Events in Lymphoma

Xiao Zhou, Shyam Teegala, Auris Huen, Yuan Ji, Luis Fayad, Fredrick B. Hagemeister, Gregory Gladish, Saroj Vadhan-Raj

Journal:

The American Journal of Medicine

Year:

2010

Language:

english

File:

PDF, 406 KB

english, 2010

50

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma

Fernando Cabanillas, Sen Pathak, Grace Grant, Fredrick B. Hagemeister, Peter McLaughun, Forrest Swan, Maria A. Rodriguez, Jose Trujillo, Ann Cork, James J. Butler, Ruth Katz, Susan Bourne, Emil J Frei

Journal:

The American Journal of Medicine

Year:

1989

Language:

english

File:

PDF, 1.34 MB

english, 1989